Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO)

NCT03722966 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
34
Enrollment
OTHER
Sponsor class

Stopped Following the Chantix recall, Pfizer stopped providing medication for the study and and new study enrollments were discontinued.

Conditions

Interventions

Sponsor

University of Oklahoma

Collaborators